Design, Synthesis and Characterization of Covalent KDM5 Inhibitors
Open Access
- 15 November 2018
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 58 (2) , 515-519
Abstract
Histone lysine demethylases (KDMs) are involved in the dynamic regulation of gene expression and they play a critical role in several biological processes. Achieving selectivity over the different KDMs has been a major challenge for KDM inhibitor development. Here we report potent and selective KDM5 covalent inhibitors designed to target cysteine residues only present in the KDM5 sub‐family. The covalent binding to the targeted proteins was confirmed by MS and time‐dependent inhibition. Additional competition assays show that compounds were non 2‐OG competitive. Target engagement and ChIP‐seq analysis showed that the compounds inhibited the KDM5 members in cells at nano‐ to micromolar levels and induce a global increase of the H3K4me3 mark at transcriptional start sites.Keywords
Funding Information
- H2020 Marie Skłodowska-Curie Actions (744389)
- Innovative Medicines Initiative (115766)
- Engineering and Physical Sciences Research Council (EP/L015838/1)
- Arthritis Research UK (20522)
- FP7 People: Marie-Curie Actions (609305)
- Wellcome Trust (106169/ZZ14/Z)
This publication has 22 references indexed in Scilit:
- Quantitative ChIP-Seq Normalization Reveals Global Modulation of the EpigenomeCell Reports, 2014
- Mechanisms of human histone and nucleic acid demethylasesCurrent Opinion in Chemical Biology, 2012
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitorsPharmacological Research, 2011
- The resurgence of covalent drugsNature Reviews Drug Discovery, 2011
- Development of homogeneous luminescence assays for histone demethylase catalysis and bindingAnalytical Biochemistry, 2010
- Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 ValuesSLAS Discovery, 2009
- JmjC-domain-containing proteins and histone demethylationNature Reviews Genetics, 2006
- Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activityMolecular Cancer Therapeutics, 2005
- Features of Selective Kinase InhibitorsChemistry & Biology, 2005
- Histone MethylationCell, 2002